90 related articles for article (PubMed ID: 6192080)
1. Non-specific normal immunosuppressive protein (Nip): purification and further biochemical characterization.
Gavison-Goren R; Nelken D
Immunology; 1983 Aug; 49(4):599-608. PubMed ID: 6192080
[TBL] [Abstract][Full Text] [Related]
2. Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells.
Hanna N; Ovadia H; Nelken D
Immunology; 1978 Jun; 34(6):1007-15. PubMed ID: 79543
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.
Morvillo V; Bover L; Mordoh J
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):779-95. PubMed ID: 8832109
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of the glycoprotein fraction with a proliferation-promoting activity on human and hamster cells in vitro from Aloe vera gel.
Yagi A; Egusa T; Arase M; Tanabe M; Tsuji H
Planta Med; 1997 Feb; 63(1):18-21. PubMed ID: 9063091
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of the immunosuppressive properties of trophoblastic beta 1-glycoprotein and placental alpha 2-microglobulin in vitro].
Gulianskiĭ LN; Petrunin DD; Fedorov GN; Tatarinov IuS
Biull Eksp Biol Med; 1987 Jul; 104(7):65-7. PubMed ID: 2441773
[TBL] [Abstract][Full Text] [Related]
6. Normal immunosuppressive protein. Isolation of a glycoprotein active fraction.
Goren R; Nelken D
Immunology; 1980 Mar; 39(3):305-9. PubMed ID: 7439928
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a Hodgkin's and B cell-associated glycoprotein.
Wan KR; Wang MJ; Taylor CR; Imam SA
Anticancer Res; 1999; 19(4B):3275-81. PubMed ID: 10652624
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
[TBL] [Abstract][Full Text] [Related]
9. Molecular and biological characterization of anticarcinogenic and tumor cell growth-inhibitory activities of Syrian hamster lymphotoxin.
Ransom JH; Evans CH
Cancer Res; 1983 Nov; 43(11):5222-7. PubMed ID: 6604574
[TBL] [Abstract][Full Text] [Related]
10. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of immunoregulatory factors from normal human serum. I. Preliminary biochemical and biological characterization of immunosuppressive factors.
Voorting-Hawking M; Michael JG
J Immunol; 1977 Feb; 118(2):505-13. PubMed ID: 190315
[TBL] [Abstract][Full Text] [Related]
12. Nonspecific immunosuppressive factors in malignant ascites: further characterization and possible relationship to erythrocyte receptors of human peripheral T cells.
Oh SK; Moolten FL
J Immunol; 1981 Dec; 127(6):2300-7. PubMed ID: 6975316
[TBL] [Abstract][Full Text] [Related]
13. Direct isolation of proteins from sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analysis by electrospray-ionization mass spectrometry.
Schuhmacher M; Glocker MO; Wunderlin M; Przybylski M
Electrophoresis; 1996 May; 17(5):848-54. PubMed ID: 8783011
[TBL] [Abstract][Full Text] [Related]
14. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
Dell'Aquila ML; Pigott DA; Bonaquist DL; Gaffney EV
J Natl Cancer Inst; 1984 Feb; 72(2):291-8. PubMed ID: 6582317
[TBL] [Abstract][Full Text] [Related]
15. Purification of human interleukin 1.
Lachman LB; Page SO; Metzgar RS
J Supramol Struct; 1980; 13(4):457-66. PubMed ID: 6785531
[TBL] [Abstract][Full Text] [Related]
16. Purification and partial characterization of a preneoplastic antigen in liver carcinogenesis.
Lin JC; Kligman L; Farber E
Cancer Res; 1980 Oct; 40(10):3755-62. PubMed ID: 7438059
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites.
Cornelius JG; Normann SJ
J Immunol; 1988 Sep; 141(6):2175-80. PubMed ID: 3139755
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid.
Oh SK; Moolten FL
Eur J Immunol; 1981 Oct; 11(10):780-8. PubMed ID: 6273181
[TBL] [Abstract][Full Text] [Related]
19. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
[TBL] [Abstract][Full Text] [Related]
20. Human coagluation factor V purification and thrombin-catalyzed activation.
Dahlbäck B
J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
